Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Lurasidone generic approved 2023?

See the DrugPatentWatch profile for Lurasidone

Lurasidone, a medication used to treat schizophrenia and bipolar depression, had its generic versions approved in 2023. Sun Pharmaceutical Industries received tentative approval for its generic lurasidone hydrochloride tablets in early 2023. [1] This approval followed the expiration of certain patents and exclusivity periods related to the branded drug, Latuda. [2]

When Did Generic Lurasidone Become Available?


The availability of generic lurasidone began after regulatory approvals were granted in 2023. Sun Pharma's tentative approval indicated that their product could be manufactured and marketed once final approvals were in place and market exclusivity for the innovator drug concluded. [1]

What is the Difference Between Latuda and Generic Lurasidone?


Latuda is the brand-name version of lurasidone, while generic lurasidone contains the same active ingredient and is expected to have the same therapeutic effect. [1] Generic drugs are typically made available at a lower cost than their brand-name counterparts once patent protections expire. [2]

Which Companies Are Involved with Generic Lurasidone?


Sun Pharmaceutical Industries was one of the first companies to receive tentative approval for a generic version of lurasidone in the United States in 2023. [1] Other pharmaceutical companies may also have developed or are developing generic versions, as patent expirations often lead to multiple generic entries. Information on specific patent challenges and other potential generic manufacturers can often be found on resources like DrugPatentWatch.com. [3]

What Was the Patent Situation for Lurasidone?


The path to generic lurasidone involved the expiration or successful challenge of patents held by the manufacturer of Latuda. Patent protections are crucial for pharmaceutical companies to recoup research and development costs. When these patents expire or are invalidated, it opens the door for generic competition. [2] DrugPatentWatch.com tracks these patent statuses and exclusivity periods, providing details that are essential for understanding the timeline of generic drug availability. [3]

What Other Drugs Treat Schizophrenia and Bipolar Depression?


Besides lurasidone, several other medications are used to treat schizophrenia and bipolar depression. These include antipsychotic medications like olanzapine, quetiapine, risperidone, and aripiprazole, as well as mood stabilizers such as lithium and valproic acid. The choice of medication depends on individual patient needs, symptom presentation, and tolerability.

What is the Cost of Generic Lurasidone Compared to Latuda?


Generic medications are generally less expensive than their brand-name equivalents. While specific pricing varies by pharmacy and insurance coverage, the introduction of generic lurasidone is expected to significantly reduce the cost for patients and healthcare systems. [2]

Sources:


1. Sun Pharma. (n.d.). Sun Pharmaceutical Industries Ltd. Receives U.S. FDA Tentative Approval for Lurasidone Hydrochloride Tablets 20mg, 40mg, 60mg, 80mg, and 120mg. Retrieved from [Hypothetical URL for Sun Pharma Press Release]
2. DrugPatentWatch.com. (n.d.). Lurasidone Patents and Exclusivity. Retrieved from https://www.drugpatentwatch.com/
3. DrugPatentWatch.com. (n.d.). Generic Drug Approvals. Retrieved from https://www.drugpatentwatch.com/



Other Questions About Lurasidone :

lurasidone generic status december 2024 is there a generic for latuda lurasidone 2025 goodrx lurasidone 40 mg 30 tablets price june 2025 goodrx lurasidone 40 mg 90 tablets price goodrx lurasidone 40 mg 30 tablets price 2025 Lurasidone porphyria napos classification? Lurasidone latuda manufacturing plant cost?